These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21388395)

  • 1. Blood-borne transmission of the measles, mumps, and rubella vaccine virus.
    Shin SY; Lee SW; Cho YH; Shin YH
    Transfusion; 2011 Mar; 51(3):663-4. PubMed ID: 21388395
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of measles, mumps, and rubella viral genomic sequences from multiple sclerosis brain tissue by polymerase chain reaction.
    Godec MS; Asher DM; Murray RS; Shin ML; Greenham LW; Gibbs CJ; Gajdusek DC
    Ann Neurol; 1992 Sep; 32(3):401-4. PubMed ID: 1416811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of measles, mumps, and rubella viruses.
    Tipples G; Hiebert J
    Methods Mol Biol; 2011; 665():183-93. PubMed ID: 21116802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of measles, mumps and rubella viruses by immuno-colorimetric assay and its application in focus reduction neutralization tests.
    Vaidya SR; Kumbhar NS; Bhide VS
    Microbiol Immunol; 2014 Dec; 58(12):666-74. PubMed ID: 25244651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.
    Al-Sukaiti N; Reid B; Lavi S; Al-Zaharani D; Atkinson A; Roifman CM; Grunebaum E
    J Allergy Clin Immunol; 2010 Oct; 126(4):868-9. PubMed ID: 20810153
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of molecular testing to confirm measles, mumps and rubella in immunised individuals.
    Speers DJ; Dowse GK
    Med J Aust; 2015 Apr; 202(6):297-8. PubMed ID: 25832147
    [No Abstract]   [Full Text] [Related]  

  • 7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH; Saracen CL; Peter G
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to measles, mumps, and rubella in newly hired (2006-2008) healthcare workers born before 1957.
    Weber DJ; Consoli S; Sickbert-Bennett E; Miller MB; Rutala WA
    Infect Control Hosp Epidemiol; 2010 Jun; 31(6):655-7. PubMed ID: 20426576
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
    Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles, mumps and rubella virus vaccines prepared from virus produced by unit process.
    McAleer WJ; Buynak EB; Weibel RE; Villarejos WM; Scattergood EM; Wasmuth EH; McLean AA; Hilleman MR
    J Biol Stand; 1975; 3(4):381-4. PubMed ID: 1184596
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
    Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
    Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantification of measles, mumps and rubella viruses using real-time quantitative TaqMan-based RT-PCR assay.
    Ammour Y; Faizuloev E; Borisova T; Nikonova A; Dmitriev G; Lobodanov S; Zverev V
    J Virol Methods; 2013 Jan; 187(1):57-64. PubMed ID: 23018058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM; Baker L; Starr SE; Plotkin SA
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
    Narayan KM; Moffat MA
    Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.